{
    "medicine_id": "03902a0f69a9c26737b154c7caddc7831bf934bf",
    "platform_id": "DB01158",
    "metadata": {
        "name": "Bretylate Inj 50mg ml 50 mg 1mL Injection",
        "composition": "50 mg 1mL Bretylium",
        "clinical_particulars": {
            "therapeutic_indications": "For use in the prophylaxis and therapy of ventricular fibrillation Also used in the treatment of life threatening ventricular arrhythmias such as ventricular tachycardia that have failed to respond to adequate doses of a first line antiarrhythmic agent such as lidocaine",
            "contraindications": {
                "disease": "Oral mouse LD sub 50 sub 400 mg kg In the presence of life threatening arrhythmias underdosing with bretylium probably presents a greater risk to the patient than potential overdosage However one case of accidental overdose has been reported in which a rapidly injected intravenous bolus of 30 mg kg was given instead of an intended 10 mg kg dose during an episode of ventricular tachycardia Marked hypertension resulted followed by protracted refractory hypotension The patient expired 18 hours later in asystole complicated by renal failure and aspiration pneumonitis Bretylium serum levels were 8000 ng mL",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bretylium is a bromobenzyl quaternary ammonium compound which selectively accumulates in sympathetic ganglia and their postganglionic adrenergic neurons where it inhibits norepinephrine release by depressing adrenergic nerve terminal excitability Bretylium also suppresses ventricular fibrillation and ventricular arrhythmias",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of orthostatic hypotension and syncope can be increased when Bretylium is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of hypotension and orthostatic hypotension can be increased when Bretylium is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Bretylium may increase the hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "Bretylium may increase the bradycardic activities of Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "Bretylium may increase the bradycardic activities of Ivabradine"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "Alfuzosin may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "Bretylium may increase the hypotensive activities of Amifostine"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Dexmethylphenidate may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "Bretylium may increase the hypotensive activities of Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "Bretylium may increase the hypotensive activities of Rituximab"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Eletriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Zolmitriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "Doxapram may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Propiomazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "Phenmetrazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Trifluoperazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Naratriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Frovatriptan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "Methoxyflurane may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "Dutasteride may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "Finasteride may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "Yohimbine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Periciazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Acepromazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Thioproperazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "Epicaptopril may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "1 benzylimidazole may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Flibanserin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Naluzotan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Cariprazine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "Mianserin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Pizotifen may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "Esmirtazapine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Vilazodone may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "Nitrous oxide may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "Saralasin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Cinitapride may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "Tyramine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "Ifenprodil may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Vortioxetine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Brexpiprazole may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Moxisylyte may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "Atipamezole may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Propiverine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Piclozotan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "Siponimod may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "Idazoxan may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "Theodrenaline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "Tramazoline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Dibenzepin may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Quinupramine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "Trichloroethylene may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "Fenozolone may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Melitracen may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Lofepramine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "Xenon may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Iprindole may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "Buflomedil may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Diethyl ether may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Imipramine oxide may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "Mefenorex may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "Deoxyepinephrine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "5 methoxy N N dimethyltryptamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "Quinoline Yellow WS may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Solriamfetol may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Phentolamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "Sufentanil may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "Tolazoline may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "Remifentanil may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "Phenoxybenzamine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Bretylium may decrease the antihypertensive activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Bretylium may decrease the antihypertensive activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "Bretylium may decrease the antihypertensive activities of Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "Bretylium may decrease the antihypertensive activities of Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "Bretylium may decrease the antihypertensive activities of Indoramin"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Bretylium may decrease the antihypertensive activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Bretylium may decrease the antihypertensive activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Bretylium may decrease the antihypertensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "Halothane may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bromocriptine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Rotigotine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "Isoxsuprine may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "Selpercatinib may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Naxitamab may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Fingolimod may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09282",
                        "description": "Molsidomine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00287",
                        "description": "Travoprost may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00869",
                        "description": "Dorzolamide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00905",
                        "description": "Bimatoprost may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06826",
                        "description": "Bretylium may increase the hypotensive activities of Unoprostone"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Valsartan may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Ramipril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Olmesartan may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Minoxidil may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Trandolapril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Benazepril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Enalapril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Doxazosin may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Labetalol may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Nitroglycerin may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Candesartan cilexetil may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Eprosartan may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Quinapril may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Irbesartan may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Bretylium may increase the hypotensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Bretylium may increase the hypotensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Bretylium may increase the hypotensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Bretylium may increase the hypotensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Bretylium may increase the hypotensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Bretylium may increase the hypotensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Bretylium may increase the hypotensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Bretylium may increase the hypotensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Bretylium may increase the hypotensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Bretylium may increase the hypotensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Bretylium may increase the hypotensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Bretylium may increase the hypotensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Bretylium may increase the hypotensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Bretylium may increase the hypotensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Bretylium may increase the hypotensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Bretylium may increase the hypotensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Bretylium may increase the hypotensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Bretylium may increase the hypotensive activities of Penbutolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Bretylium may increase the hypotensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Bretylium may increase the hypotensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Bretylium may increase the hypotensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Bretylium may increase the hypotensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Bretylium may increase the hypotensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Bretylium may increase the hypotensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Bretylium may increase the hypotensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Bretylium may increase the hypotensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Bretylium may increase the hypotensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Bretylium may increase the hypotensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Bretylium may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Bretylium may increase the hypotensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Bretylium may increase the hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Bretylium may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Bretylium may increase the hypotensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Bretylium may increase the hypotensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Bretylium may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Bretylium may increase the hypotensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Bretylium may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Bretylium may increase the hypotensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Bretylium may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Bretylium may increase the hypotensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Bretylium may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Bretylium may increase the hypotensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Bretylium may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Bretylium may increase the hypotensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Bretylium may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Bretylium may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Bretylium may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Bretylium may increase the hypotensive activities of Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Bretylium may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Bretylium may increase the hypotensive activities of Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Bretylium may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Bretylium may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Bretylium may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Bretylium may increase the hypotensive activities of Epanolol"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Bretylium may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Bretylium may increase the hypotensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Bretylium may increase the hypotensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Bretylium may increase the hypotensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Bretylium may increase the hypotensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Bretylium may increase the hypotensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Bretylium may increase the hypotensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Bretylium may increase the hypotensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Bretylium may increase the hypotensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Bretylium may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "Sildenafil may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "Dipyridamole may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "Ibudilast may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "Avanafil may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "Udenafil may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Doxofylline may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "Mirodenafil may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may increase the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Carteolol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Bretylium may increase the arrhythmogenic activities of Metipranolol"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "Lidocaine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Mexiletine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Tocainide may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Bretylium may increase the arrhythmogenic activities of Aprindine"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Bretylium may increase the arrhythmogenic activities of Sparteine"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fasudil"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Bretylium may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Bretylium may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Bretylium may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Bretylium may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Bretylium may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "Bretylium may increase the arrhythmogenic activities of SOR C13"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Bretylium may increase the arrhythmogenic activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Bretylium may increase the arrhythmogenic activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Bretylium may increase the arrhythmogenic activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Bretylium may increase the arrhythmogenic activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Bretylium may increase the arrhythmogenic activities of Adenosine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Bretylium may increase the arrhythmogenic activities of Loperamide"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "Bretylium may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Bretylium may increase the arrhythmogenic activities of Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Bretylium may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Bretylium may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Bretylium may increase the arrhythmogenic activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Bretylium may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Bretylium may increase the arrhythmogenic activities of Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Bretylium may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Bretylium may increase the arrhythmogenic activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Bretylium may increase the arrhythmogenic activities of Eperisone"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Bretylium may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Bretylium may increase the arrhythmogenic activities of Benidipine"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Bretylium may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Bretylium may increase the arrhythmogenic activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Bretylium may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Bretylium may increase the arrhythmogenic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Bretylium may increase the arrhythmogenic activities of Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Bretylium may increase the arrhythmogenic activities of Flunarizine"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Bretylium may increase the arrhythmogenic activities of Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Bretylium may increase the arrhythmogenic activities of Dotarizine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Bretylium may increase the arrhythmogenic activities of Agmatine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Bretylium may increase the arrhythmogenic activities of Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Bretylium may increase the arrhythmogenic activities of Darodipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Bretylium may increase the arrhythmogenic activities of Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Bretylium may increase the arrhythmogenic activities of Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Bretylium may increase the arrhythmogenic activities of Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Bretylium may increase the arrhythmogenic activities of Caroverine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "Bretylium may increase the arrhythmogenic activities of WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Bretylium may increase the arrhythmogenic activities of Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Bretylium may increase the arrhythmogenic activities of Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Bretylium may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Bretylium may increase the arrhythmogenic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Bretylium may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Bretylium may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Bretylium may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Bretylium may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Bretylium may increase the arrhythmogenic activities of Terodiline"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Levomenthol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "Perhexiline may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Bretylium may increase the arrhythmogenic activities of Encainide"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Bretylium may increase the arrhythmogenic activities of Digitoxin"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "Bretylium may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Bretylium may increase the arrhythmogenic activities of Methsuximide"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "Bretylium may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Bretylium may increase the arrhythmogenic activities of Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cariporide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Bretylium may increase the arrhythmogenic activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Bretylium may increase the arrhythmogenic activities of Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Bretylium may increase the arrhythmogenic activities of Aranidipine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Bretylium may increase the arrhythmogenic activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Bretylium may increase the arrhythmogenic activities of Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Bretylium may increase the arrhythmogenic activities of Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Bretylium may increase the arrhythmogenic activities of Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Bretylium may increase the arrhythmogenic activities of Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Bretylium may increase the arrhythmogenic activities of Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Bretylium may increase the arrhythmogenic activities of Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Lercanidipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Nicardipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Losartan may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Felodipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Nitrendipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Carvedilol may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Bretylium may increase the arrhythmogenic activities of Alprenolol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Bretylium may increase the arrhythmogenic activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Bretylium may increase the arrhythmogenic activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Bretylium may increase the arrhythmogenic activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Bretylium may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bretylium may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Bretylium may increase the arrhythmogenic activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Bretylium may increase the arrhythmogenic activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Bretylium may increase the arrhythmogenic activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Bretylium may increase the arrhythmogenic activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Bretylium may increase the arrhythmogenic activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Bretylium may increase the arrhythmogenic activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Bretylium may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Bretylium may increase the arrhythmogenic activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Bretylium may increase the arrhythmogenic activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Bretylium may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Clevidipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Cilnidipine may increase the arrhythmogenic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Bretylium may increase the arrhythmogenic activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Treprostinil may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "Iloprost may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB14337",
                        "description": "Salvia miltiorrhiza root may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "Primidone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Phenobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of adverse effects can be increased when Streptokinase is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ropinirole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of adverse effects can be increased when Triamterene is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "The risk or severity of adverse effects can be increased when Pramipexole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when Nabilone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The risk or severity of adverse effects can be increased when Amiloride is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Methazolamide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The risk or severity of adverse effects can be increased when Tamsulosin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of adverse effects can be increased when Mannitol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The risk or severity of adverse effects can be increased when Conivaptan is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of adverse effects can be increased when Bumetanide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Diclofenamide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "The risk or severity of adverse effects can be increased when Carbetocin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "The risk or severity of adverse effects can be increased when Nesiritide is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The risk or severity of adverse effects can be increased when Empagliflozin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Dinutuximab is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "The risk or severity of adverse effects can be increased when Nitrous acid is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The risk or severity of adverse effects can be increased when Arotinolol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of adverse effects can be increased when Fimasartan is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Pipamperone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "The risk or severity of adverse effects can be increased when Sacubitril is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "Midodrine may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "Alfentanil may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "Rivastigmine may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB04897",
                        "description": "Bretylium may increase the bradycardic activities of Lucinactant"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "Bretylium may increase the bradycardic activities of Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06415",
                        "description": "Bretylium may increase the bradycardic activities of Calfactant"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "Bretylium may increase the bradycardic activities of Bufuralol"
                    },
                    {
                        "drugbank-id": "DB06761",
                        "description": "Bretylium may increase the bradycardic activities of Beractant"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "Bretylium may increase the bradycardic activities of Lanreotide"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bretylium may increase the bradycardic activities of Bopindolol"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Bretylium may increase the bradycardic activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "Bretylium may increase the bradycardic activities of Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09113",
                        "description": "Bretylium may increase the bradycardic activities of Poractant alfa"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "Bretylium may increase the bradycardic activities of Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "Bretylium may increase the bradycardic activities of Bucindolol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Bretylium may increase the bradycardic activities of Mepindolol"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "Donepezil may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Icosapent"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Mesalazine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tolmetin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Fenoprofen"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Valdecoxib"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Sulindac"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Carprofen"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Salicylic acid"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Meclofenamic acid"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Oxaprozin"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Balsalazide"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Olsalazine"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Lumiracoxib"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Taxifolin"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Oxyphenbutazone"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Licofelone"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Benoxaprofen"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Metamizole"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Zomepirac"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Cimicoxib"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Azapropazone"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Salicylamide"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Kebuzone"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Isoxicam"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Indoprofen"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ibuproxam"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Fenbufen"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Etofenamate"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Epirizole"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Flunixin"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Polmacoxib"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ebselen"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with NS 398"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Flurbiprofen axetil"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Bretylium may increase the hypotensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Bretylium may increase the antihypertensive activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Bretylium may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The therapeutic efficacy of Isoetharine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The therapeutic efficacy of Etomidate can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The therapeutic efficacy of Metaraminol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The therapeutic efficacy of Epinephrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The therapeutic efficacy of Methoxamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The therapeutic efficacy of Dobutamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The therapeutic efficacy of Ritodrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The therapeutic efficacy of Bitolterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The therapeutic efficacy of Arbutamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The therapeutic efficacy of Pergolide can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The therapeutic efficacy of Ergometrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The therapeutic efficacy of Fenoterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The therapeutic efficacy of Ephedrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The therapeutic efficacy of Procaterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The therapeutic efficacy of Bambuterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The therapeutic efficacy of 4 Methoxyamphetamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "The therapeutic efficacy of 4 Bromo 2 5 dimethoxyphenethylamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The therapeutic efficacy of Phendimetrazine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The therapeutic efficacy of Amibegron can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The therapeutic efficacy of Solabegron can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The therapeutic efficacy of Droxidopa can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The therapeutic efficacy of Isometheptene can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The therapeutic efficacy of Naphazoline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The therapeutic efficacy of Protokylol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The therapeutic efficacy of Adrafinil can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The therapeutic efficacy of Etilefrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The therapeutic efficacy of Cirazoline can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The therapeutic efficacy of Synephrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The therapeutic efficacy of Racepinephrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The therapeutic efficacy of DL Methylephedrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The therapeutic efficacy of Amitraz can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The therapeutic efficacy of Medetomidine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The therapeutic efficacy of Xylazine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The therapeutic efficacy of Ractopamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The therapeutic efficacy of Romifidine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The therapeutic efficacy of Detomidine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The therapeutic efficacy of Etafedrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The therapeutic efficacy of PF 00610355 can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The therapeutic efficacy of Abediterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The therapeutic efficacy of Dopexamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The therapeutic efficacy of Batefenterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The therapeutic efficacy of Higenamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The therapeutic efficacy of Reproterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The therapeutic efficacy of Octopamine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The therapeutic efficacy of Rimiterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The therapeutic efficacy of Tretoquinol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The therapeutic efficacy of Prenalterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The therapeutic efficacy of Xamoterol can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "The therapeutic efficacy of Racephedrine can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "The therapeutic efficacy of Chloride ion can be decreased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The therapeutic efficacy of Bretylium can be decreased when used in combination with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "The risk or severity of hypotension can be increased when Carbidopa is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of hypotension can be increased when Prazosin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of hypotension can be increased when Clonidine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Bretylium may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Bretylium may increase the hypotensive activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Bretylium may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "Lasmiditan may increase the bradycardic activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of adverse effects can be increased when Bretylium is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Cyclothiazide can be increased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Trichlormethiazide can be increased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Polythiazide can be increased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Cyclopenthiazide can be increased when used in combination with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Bretylium can be increased when used in combination with Indapamide"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of the active metabolites of Bretylium can be increased when Bretylium is used in combination with Octreotide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}